Complement Component C5a Recombinant Protein
Product Specifications
Background
Complement Component C5a (C5a) is also known as C5, and is a protein fragment released from complement component C5., is a potent chemotactic factor for human peripheral blood neutrophils and monocytes, and is believed to play an important role in a number of inflammatory conditions. There are several functions in the below: C5a is an anaphylatoxin, causing the release of histamine from mast cells; C5a is effective leukocyte chemoattractants, causing the accumulation of white blood cells, especially neutrophil granulocytes, at sites of complement activation; C5a activates white blood cells by increasing avidity for white blood cell integrins and upregulating the Lipoxygenase pathway for arachidonic acid metabolism; C5a is a powerful inflammatory mediator, and seems to be a key factor in the development of pathology of many inflammatory diseases involving the complement system; C5a modulates balance between activating versus inhibitory IgG Fc receptors on leukocytes, thereby enhancing autoimmune response.
CAS Number
9000-83-3
NCBI Gene ID
102125658
Accession Number
XP_015292262.1
Tag
Fc Tag
Type
Recombinant Proteins
Source
HEK293 cells
Purity
>90% as determined by SDS-PAGE.
Buffer
Tris with Glycine, Arginine and NaCl, pH7.5
Shipping Conditions
Room Temp
Storage Conditions
Lyophilized Protein should be stored at -20˚ C or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20˚ C or -70˚ C. Avoid repeated freeze-thaw cycles.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=11-315
Calculated Molecular Weight
34.6 kDa
Applications Notes
This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 34.6 kDa. The protein migrates as 38-40 kDa and 41-44 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
NCBI Official Name
ComplementC5
NCBI Organism
Macaca fascicularis
Background Reference 01
Gerard, C. and N.P. Gerard, 1994, Annu. Rev. Immunol.12:775.
Background Reference 02
Monk, PN. et al., 2007, British Journal of Pharmacology. 152: 429-48.
Background Reference 03
Reis ES, et al., 2011, Brain Behav Immun. Apr 23.
Background Reference 04
Bergseth G, et al., 2011, Ann Thorac Surg., 91 (2) :527-33.
Other Product Names
C5a, Complement Component 5a
Tested Applications
ELISA, WB
Species
Human
Physical Properties
Lyophilized
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items